Predictions
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.17
03.11.21
03.11.21
-
03.11.22
03.11.22
-8.41%
15.11.21
15.11.21
Risky Investment
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.93
01.11.21
01.11.21
€10.80
01.11.22
01.11.22
-21.90%
05.12.21
05.12.21
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.86
27.10.21
27.10.21
€40.00
31.12.23
31.12.23
-59.32%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€30.01
25.10.21
25.10.21
-
25.10.22
25.10.22
-1.37%
31.10.21
31.10.21
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.45
18.10.21
18.10.21
€12.00
31.12.23
31.12.23
-2.68%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.49
10.10.21
10.10.21
€5.00
31.12.23
31.12.23
-32.83%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.00
05.10.21
05.10.21
-
05.10.22
05.10.22
-10.00%
08.12.21
08.12.21
Probably not worthwhile Investment
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.40
04.10.21
04.10.21
-
04.10.22
04.10.22
45.45%
10.08.22
10.08.22
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.92
28.09.21
28.09.21
-
28.09.22
28.09.22
-6.85%
02.10.21
02.10.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.96
25.08.21
25.08.21
-
25.08.22
25.08.22
4.84%
05.09.21
05.09.21
Risky Investment
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.83
17.08.21
17.08.21
-
17.08.22
17.08.22
-9.02%
22.08.21
22.08.21
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.95
05.08.21
05.08.21
-
05.08.22
05.08.22
23.44%
08.08.21
08.08.21
Could be worthwhile Investment >10% per year
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.71
15.07.21
15.07.21
-
15.07.22
15.07.22
1.92%
23.04.22
23.04.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.45
10.07.21
10.07.21
€1.90
10.07.22
10.07.22
23.96%
11.11.21
11.11.21
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
08.07.21
08.07.21
-
08.07.22
08.07.22
13.98%
08.07.22
08.07.22
Enwave Corporation
Start price
Target price
Perf. (%)
€0.71
01.07.21
01.07.21
€1.10
01.07.22
01.07.22
-35.41%
02.07.22
02.07.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.23
28.06.21
28.06.21
-
28.06.22
28.06.22
-24.89%
29.06.22
29.06.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.38
28.06.21
28.06.21
€2.50
28.06.22
28.06.22
-71.16%
29.06.22
29.06.22
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.26
12.06.21
12.06.21
€1.00
12.06.22
12.06.22
-14.11%
26.06.21
26.06.21
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€9.52
27.05.21
27.05.21
€32.00
27.05.22
27.05.22
-55.61%
28.05.22
28.05.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Aptose Biosciences
Start price
Target price
Perf. (%)
€4.64
01.05.21
01.05.21
€4.50
01.05.22
01.05.22
-30.60%
11.06.21
11.06.21
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€8.92
26.04.21
26.04.21
-
26.04.22
26.04.22
-38.92%
08.02.22
08.02.22